Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: Evaluation of elemental strontium as a molecular tracer of bone formation

Osteoarthritis and Cartilage

Volumn 20, Issue 7, 2012, Pages 694-702

  Panahifar, A ^a   Maksymowych, W P ^a   Doschak, M R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Alendronate; Electron probe microanalysis; Micro CT; Osteophyte; Strontium ranelate

Indexed keywords

ALENDRONIC ACID; STRONTIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; DRUG LABELING; DRUG MECHANISM; ELECTRON PROBE MICROANALYSIS; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; MENISCECTOMY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; POSTTRAUMATIC OSTEOARTHRITIS; PRIORITY JOURNAL; RAT;

ALENDRONATE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY CONSERVATION AGENTS; DRUG EVALUATION, PRECLINICAL; ELECTRON PROBE MICROANALYSIS; FEMALE; MENISCI, TIBIAL; ORGANOMETALLIC COMPOUNDS; OSTEOARTHRITIS; OSTEOGENESIS; OSTEOPHYTE; RATS; RATS, SPRAGUE-DAWLEY; THIOPHENES; X-RAY MICROTOMOGRAPHY;

EID: 84862135817     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.03.021     Document Type: Article

References (36)

1. Ornetti P., Brandt K., Hellio-Le Graverand M.P., Hochberg M., Hunter D.J., Kloppenburg M., et al. OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage 2009 Jul, 17(7):856-863.
2. Neogi T., Felson D., Niu J., Nevitt M., Lewis C.E., Aliabadi P., et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009 Aug 21, 339:b2844.
3. Hayami T., Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004, 50(4):1193-1206.
4. Jones M.D., Tran C.W., Li G., Maksymowych W.P., Zernicke R.F., Doschak M.R. In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat. Arthritis Rheum 2010 Sep, 62(9):2726-2735.
5. Neogi T., Nevitt M.C., Ensrud K.E., Bauer D., Felson D.T. The effect of alendronate on progression of spinal osteophytes and disc-space narrowing. Ann Rheum Dis 2008 Oct, 67(10):1427-1430.
6. Doschak M.R., Wohl G.R., Hanley D.A., Bray R.C., Zernicke R.F. Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee. J Orthop Res 2004, 22(5):942-948.
7. Bingham C.O., Buckland-Wright J.C., Garnero P., Cohen S.B., Dougados M., Adami S., et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006 Nov, 54(11):3494-3507.
8. Boivin G., Farlay D., Khebbab M.T., Jaurand X., Delmas P.D., Meunier P.J. In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization. Osteoporos Int 2010, 21(4):667-677.
9. Göran C., Bauer H. The use of radionuclides in orthopaedics: radionuclide scintimetry of the skeleton. J Bone Joint Surg Am 1968, 50:1681-1709.
10. Li C., Paris O., Siegel S., Roschger E.P., Paschalis E.P., Fratzl P. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. J Bone Miner Res 2010, 25(5):968-975.
11. Bauer G.C., Smith E.M. 85Sr scintimetry in osteoarthritis of the knee. J Nucl Med 1969 Mar, 10(3):109-116.
12. Ben-Josef E., Lucas D.R., Vasan S., Porter A.T. Selective accumulation of strontium-89 in metastatic deposits in bone: radio-histological correlation. Nucl Med Commun 1995 Jun, 16(6):457-463.
13. Gerson B.D., Dorfman H.D., Norman A., Mankin H.J. Patterns of localization of 85 strontium in osteosarcoma. A correlative study using gross autoradiography. J Bone Joint Surg Am 1972 Jun, 54(4):817-827.
14. van der Kraan P.M., van den Berg W.B. Osteophytes: relevance and biology. Osteoarthritis Cartilage 2007 Mar, 15(3):237-244.
15. Cicuttini F.M., Baker J., Hart D.J., Spector T.D. Association of pain with radiological changes in different compartments and views of the knee joint. Osteoarthritis Cartilage 1996, 4:143-147.
16. Torres L., Dunlop D.D., Peterfy C., Guermazi A., Prasad P., Hayes K.W., et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006 Oct, 14(10):1033-1040.
17. Sengupta M., Zhang Y.Q., Niu J.B., Guermazi A., Grigorian M., Gale D., et al. High signal in knee osteophytes is not associated with knee pain. Osteoarthritis Cartilage 2006 May, 14(5):413-417.
18. Howell D.S., Altman R.D., Pelletier J.-P., Martel-Pelletier J., Dean D.D. Disease-modifying antirheumatic drugs: current status of their application in animal models of osteoarthritis. Osteoarthritic Disorders 1995, American Academy of Orthopaedic Surgeons Press, Chicago. K.E. Kuettner, V.E. Goldberg (Eds.).
19. Myers S.L., Brandt K.D., Burr D.B., O'Connor B.L., Albrecht M. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis. J Rheumatol 1999 Dec, 26(12):2645-2653.
20. Spector T.D. Bisphosphonates: potential therapeutic agents for disease modification in osteoarthritis. Aging Clin Exp Res 2003 Oct, 15(5):413-418.
21. Doschak M.R., LaMothe J.M., Cooper D.M., Hallgrimsson B., Hanley D.A., Bray R.C., et al. Bisphosphonates reduce bone mineral loss at ligament entheses after joint injury. Osteoarthritis Cartilage 2005 Sep, 13(9):790-797.
22. Bendele A.M. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact 2001 Jun, 1(4):363-376.
23. Marie PJ. Activity of S12911-2 on the rat immobilisation model of osteoporosis. Histomorphometry: chemical analysis of bones - osteocalcin and blood strontium level. IRIS Report PHA-12911-040-FRA/003, 1991.
24. Boyd S.K., Szabo E., Ammann P. Increased bone strength is associated with improved bone microarchitecture in intact female rats treated with strontium Ranelate: a finite element analysis study. Bone 2011, 48:1109-1116.
25. Batiste D.L., Kirkley A., Laverty S., Thain L.M., Spouge A.R., Holdsworth D.W. Ex vivo characterization of articular cartilage and bone lesions in a rabbit ACL transection model of osteoarthritis using MRI and micro-CT. Osteoarthritis Cartilage 2004 Dec, 12(12):986-996.
26. Ralis Z.A., Watkins G. Modified tetrachrome method for osteoid and defectively mineralized bone in paraffin sections. Biotech Histochem 1992 Nov, 67(6):339-345.
27. Bauer G.C. The use of radionuclides in orthopaedics. IV. Radionuclide scintimetry of the skeleton. J Bone Joint Surg Am 1968 Dec, 50(8):1681-1709.
28. Burr D.B. Increased biological activity of subchondral mineralized tissues underlies the progressive deterioration of articular cartilage in osteoarthritis. J Rheumatol 2005 Jun, 32(6):1156-1159.
29. Buckland-Wright J.C., Messent E.A., Bingham C.O., Ward R.J., Tonkin C. A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) 2007 Feb, 46(2):257-264.
30. Yao W., Balooch G., Balooch M., Jiang Y., Nalla R.K., Kinney J., et al. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization. Bone 2006 Sep, 39(3):460-469.
31. Amagase K., Hayashi S., Nishikawa K., Aihara E., Takeuchi K. Impairment of gastric ulcer healing by alendronate, a nitrogen-containing bisphosphonate, in rats. Dig Dis Sci 2007 Aug, 52(8):1879-1889.
32. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., Phenekos C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005 May, 90(5):2816-2822.
33. Reginster J.Y., Bruyère O., Sawicki A., Roces-Varela A., Fardellone P., Roberts A., et al. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Bone 2009 Dec, 45(6):1059-1064.
34. Farlay D., Boivin G., Panczer G., Lalande A., Meunier P.J. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 2005 Sep, 20(9):1569-1578.
35. Boivin G., Deloffre P., Perrat B., Panczer G., Boudeulle M., Mauras Y., et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 1996 Sep, 11(9):1302-1311.
36. Van Der Sluijs J.A., Geesink R.G., Van Der Linden A.J., Bulstra S.K., Kuyer R., Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res 1992 Jan, 10(1):58-61.